# ImmunityBio, Inc. (IBRX) — Net Income

## Annual Net Income (USD)

| Year | Net Income |
| --- | --- |
| 2025 | -$351M |
| 2024 | -$414M |
| 2023 | -$583M |
| 2022 | -$417M |
| 2021 | -$347M |
| 2020 | -$222M |
| 2019 | -$158M |
| 2018 | -$96M |
| 2017 | -$96M |
| 2016 | -$121M |
| 2015 | -$237M |
| 2014 | -$6M |
| 2013 | -$2M |

## Quarterly Net Income (USD)

| Quarter | Net Income |
| --- | --- |
| 2026-03-31 | -$633M |
| 2025-09-30 | -$67M |
| 2025-06-30 | -$93M |
| 2025-03-31 | -$130M |
| 2024-09-30 | -$86M |
| 2024-06-30 | -$135M |
| 2024-03-31 | -$134M |
| 2023-09-30 | -$96M |
| 2023-06-30 | -$138M |
| 2023-03-31 | -$116M |
| 2022-09-30 | -$111M |
| 2022-06-30 | -$95M |
| 2022-03-31 | -$103M |
| 2021-09-30 | -$88M |
| 2021-06-30 | -$88M |
| 2021-03-31 | -$80M |
| 2020-09-30 | -$66M |
| 2020-06-30 | -$51M |
| 2020-03-31 | -$37M |
| 2019-09-30 | -$16M |
| 2019-06-30 | -$17M |
| 2019-03-31 | -$18M |
| 2018-09-30 | -$24M |
| 2018-06-30 | -$28M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/IBRX/net-income)
